Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$13.53
-3.1%
$13.77
$6.62
$17.67
$1.16B1.26853,942 shs1.56 million shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$1.81
+3.1%
$2.07
$1.35
$4.07
$77.78M0.65354,251 shs760,733 shs
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
$1.12
$1.12
$0.63
$5.07
$13.13M2.29210,209 shsN/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$0.00
C$0.12
C$2.50
C$21.27MN/A68,686 shs239,293 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.00%-9.13%+8.24%-13.10%+79.68%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.00%+28.01%-15.65%-28.94%-43.77%
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
0.00%0.00%0.00%0.00%0.00%
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
1.3497 of 5 stars
2.23.00.00.03.51.70.0
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
1.8477 of 5 stars
3.51.00.00.02.31.70.6
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/AN/AN/AN/AN/AN/AN/AN/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.33
Hold$16.6723.18% Upside
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
3.00
Buy$2.8557.89% Upside
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
0.00
N/AN/AN/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest REUN, QIPT, MD, and TRL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.00 ➝ $4.00
5/13/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$4.00 ➝ $1.70
5/12/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.50 ➝ $16.00
5/8/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$19.00 ➝ $20.00
4/11/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$18.00 ➝ $16.00
(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$1.98B0.59$2.76 per share4.91$8.91 per share1.52
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$240.85M0.32$0.71 per share2.56$2.47 per share0.73
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
$3.88M3.38N/AN/A$1.37 per share0.82
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$407.64M0.00N/A0.77C$0.38 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-$60.41M-$1.01N/A10.101.74-4.92%15.47%5.64%8/5/2025 (Estimated)
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.21N/AN/AN/A-2.90%-6.70%-2.94%8/13/2025 (Estimated)
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
-$36.69MN/A0.00N/AN/AN/A-91.82%-64.58%N/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/AC$6.340.04N/A0.86N/AN/AN/AN/A

Latest REUN, QIPT, MD, and TRL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q2 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.02-$0.07-$0.09-$0.07$88.29 million$57.40 million
5/6/2025Q1 2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.25$0.33+$0.08$0.24$451.44 million$458.36 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/AN/AN/AN/AN/A
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
C$1.31704.17%N/A20.69%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.81
1.60
1.42
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.74
1.22
0.87
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
N/A
3.51
3.51
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
N/A
5.92
3.87
CompanyEmployeesShares OutstandingFree FloatOptionable
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
7,85085.91 million84.16 millionOptionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
80043.09 million37.32 millionOptionable
Reunion Neuroscience Inc. stock logo
REUN
Reunion Neuroscience
1611.72 millionN/ANot Optionable
Trilogy International Partners Inc. stock logo
TRL
Trilogy International Partners
70,00088.63 millionN/ANot Optionable

Recent News About These Companies

Trilogy International Partners Inc TRL.H
Trilogy International Ltd (TIL)
Trilogy International Partners GAAP EPS of -$0.03

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Pediatrix Medical Group stock logo

Pediatrix Medical Group NYSE:MD

$13.53 -0.44 (-3.15%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$13.56 +0.03 (+0.18%)
As of 05/23/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$1.80 +0.06 (+3.14%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$1.84 +0.04 (+1.94%)
As of 05/23/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Reunion Neuroscience stock logo

Reunion Neuroscience NASDAQ:REUN

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.

Trilogy International Partners stock logo

Trilogy International Partners TSE:TRL

Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services in New Zealand, Bolivia, and internationally. It offers prepaid and postpaid payment plans, including local, international long distance, and roaming services to customers and international visitors roaming on its networks. The company also provides fixed broadband communications to residential and enterprise customers, as well as a range of mobile and fixed line services in New Zealand and Australia; and fixed public telephony and wireless broadband services in Bolivia. As of December 31, 2021, it had a distribution network of approximately 13 company owned stores, 170 dealers, and 8,300 other dealer points of presence in Bolivia; and a distribution network of approximately 20 company owned retail stores, 40 independent dealers, and 2,500 points of sale through national retail chains and grocery stores in New Zealand. The company's services cover an aggregate population of 16.8 million users. It also provides services through its online self-service store in New Zealand; and operates under the Viva brand name in Bolivia. Trilogy International Partners Inc. was founded in 1982 and is headquartered in Bellevue, Washington.